Clinical and coronary angiographic characteristics of patients with coronary slow flow

被引:74
作者
Yilmaz, Hueseyin [1 ]
Demir, Ibrahim [1 ]
Uyar, Zebra [1 ]
机构
[1] Akdeniz Univ, Tip Fak, Kardiyol Anabilim Dali, Sch Med, TR-07070 Antalya, Turkey
关键词
obesity; body mass index; coronary atherosclerosis; angiography; slow coronary flow;
D O I
10.2143/AC.63.5.2033224
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - The coronary slow flow phenomenon is an angiographic finding characterized by delayed distal vessel opacification in the absence of significant epicardial coronary disease, and is an important clinical entity because it may be the cause of angina at rest or during exercise, acute myocardial infarction, and hypertension. The pathophysiological mechanisms of the coronary slow flow phenomenon remain undetermined. Endothelial dysfunction and microvascular dysfunction have been suggested as underlying mechanisms. The slow coronary flow (SCF) phenomenon is considered to be a form of early phase atherosclerosis in some studies. A study of patients with SCF was conducted to determine the associated clinical and angiographic properties. Method - Eighty-five patients with SCIF and 85 control subjects without SCF were included in the study. All subjects had angiographically proven normal coronary arteries. Coronary flow patterns of the latter were determined by the thrombolysis in myocardial infarction frame count method. Clinical and angiographic characteristics of the patients were obtained from case records. Results - Patients with SCF had higher total cholesterol, and LDL-C levels. Body mass index (BMI) was higher and metabolic syndrome was more frequent in SCF compared to control subjects. Patients with SCF were more symptomatic than the control group, and hospital admissions were also more frequent. BMI correlated statistically significantly, but weakly, with mean TIMI frame count for the 3 coronary arteries. Conclusion - In this study we demonstrated that patients with SCF had a significant metabolic disarrangement compared to the control group. Patients with SCF have a high incidence of metabolic syndrome which leads to development of coronary microvascular dysfunction via several mechanisms.
引用
收藏
页码:579 / 584
页数:6
相关论文
共 40 条
[11]   IMPAIRED VASODILATION OF FOREARM RESISTANCE VESSELS IN HYPERCHOLESTEROLEMIC HUMANS [J].
CREAGER, MA ;
COOKE, JP ;
MENDELSOHN, ME ;
GALLAGHER, SJ ;
COLEMAN, SM ;
LOSCALZO, J ;
DZAU, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :228-234
[12]   CLINICAL AND ARTERIOGRAPHIC CHARACTERIZATION OF PATIENTS WITH UNSTABLE ANGINA WITHOUT CRITICAL CORONARY ARTERIAL NARROWING (FROM THE TIMI-IIIA TRIAL) [J].
DIVER, DJ ;
BIER, JD ;
FERREIRA, PE ;
SHARAF, BL ;
MCCABE, C ;
THOMPSON, B ;
CHAITMAN, B ;
WILLIAMS, DO ;
BRAUNWALD, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1994, 74 (06) :531-537
[13]  
Einhorn Daniel, 2003, Endocr Pract, V9, P237
[14]   HEMODYNAMIC PRINCIPLES IN THE CONTROL OF CORONARY BLOOD-FLOW [J].
EPSTEIN, SE ;
CANNON, RO ;
TALBOT, TL .
AMERICAN JOURNAL OF CARDIOLOGY, 1985, 56 (09) :E4-E10
[15]   Elevated level of plasma homocysteine in patients with slow coronary flow [J].
Erbay, AR ;
Turhan, H ;
Yasar, AS ;
Ayaz, S ;
Sahin, O ;
Senen, K ;
Sasmaz, H ;
Yetkin, E .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 102 (03) :419-423
[16]   TIMI frame count: A quantitative method of assessing coronary artery flow [J].
Gibson, CM ;
Cannon, CP ;
Daley, WL ;
Dodge, JT ;
Alexander, B ;
Marble, SJ ;
McCabe, CH ;
Raymond, L ;
Fortin, T ;
Poole, WK ;
Braunwald, E .
CIRCULATION, 1996, 93 (05) :879-888
[17]   Slow coronary flow: A distinct angiographic subgroup in syndrome X [J].
Goel, PK ;
Gupta, SK ;
Agarwal, A ;
Kapoor, A .
ANGIOLOGY, 2001, 52 (08) :507-514
[18]   Adiponectin: A novel adipokine linking adipocytes and vascular function [J].
Goldstein, BJ ;
Scalia, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2563-2568
[19]   The role of TNFα and TNF receptors in obesity and insulin resistance [J].
Hotamisligil, GS .
JOURNAL OF INTERNAL MEDICINE, 1999, 245 (06) :621-625
[20]   Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women [J].
Hu, G ;
Qiao, Q ;
Tuomilehto, J ;
Balkau, B ;
Borch-Johnsen, K ;
Pyorala, K .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (10) :1066-1076